North Annette
- SEC CIK
- 0001341011
No open-market purchases or sales filed in the past year.
Current role at each company
- TPTX Turning Point Therapeutics, Inc.EVP & General Counselas of Feb 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists North Annette as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 (view filing) | Feb 9 | 2 days | North AnnetteEVP & General Counsel | SSale | −669 | $36.30 | −$24.3K | −5.4%11.7K after | |
| Aug 31, 2021 (view filing) | Aug 30 | 1 day | North AnnetteEVP, General Counsel & Secty. | SSale | −10.0K | $80.00 | −$800.0K | −44.7%12.4K after |